Impact of a personalized, fire-to-target lipid-lowering strategy in patients with acute coronary syndrome

Leqvio (inclisiran) - Novartis

Nexletol (bempedoic acid) - Esperion Therap, CSL Behring

ezetimibe - Generic mfg.

J Herrera1; J Lopez Aguilera1; J Castillo1; C Herrera2; R Gonzalez1; S Ojeda1; M Anguita1

May 11, 2026